Chimeric antigen receptor T-cell (CAR-T) cell therapy in Hungary in paediatric acute lymphoblastic leukaemia (ALL) and adult diffuse large B-cell lymphoma (DLBCL) disorders (Q3911376): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: EU contribution (P835): 3,593,115.942 euro) |
(Changed an Item: Fixing rounding issue) |
||||||||||||||
Property / EU contribution | |||||||||||||||
3,593,115.94 Euro
| |||||||||||||||
Property / EU contribution: 3,593,115.94 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / EU contribution: 3,593,115.94 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.00276521 Euro
| |||||||||||||||
Property / EU contribution: 3,593,115.94 Euro / qualifier | |||||||||||||||
point in time: 3 December 2021
|
Revision as of 23:22, 14 December 2021
Project Q3911376 in Hungary
Language | Label | Description | Also known as |
---|---|---|---|
English | Chimeric antigen receptor T-cell (CAR-T) cell therapy in Hungary in paediatric acute lymphoblastic leukaemia (ALL) and adult diffuse large B-cell lymphoma (DLBCL) disorders |
Project Q3911376 in Hungary |
Statements
1,299,400,748 forint
0 references
3,739,026.473 Euro
0.0027336256 Euro
14 December 2021
0 references
1,367,790,261.053 forint
0 references
94.999998 percent
0 references
1 February 2021
0 references
1 February 2023
0 references
DÉL-PESTI CENTRUMKÓRHÁZ-ORSZÁGOS HEMATOLÓGIAI ÉS INFEKTOLÓGIAI INTÉZET
0 references
Budapest, Budapest
0 references
Identifiers
EFOP-5.2.6-20-2020-00010
0 references